Current Controversies in Arthroscopic Partial Meniscectomy
- PMID: 35727503
- PMCID: PMC9463417
- DOI: 10.1007/s12178-022-09770-7
Current Controversies in Arthroscopic Partial Meniscectomy
Abstract
Purpose of review: Given the continued controversy among orthopedic surgeons regarding the indications and benefits of arthroscopic partial meniscectomy (APM), this review summarizes the current literature, indications, and outcomes of partial meniscectomy to treat symptomatic meniscal tears.
Recent findings: In patients with symptomatic meniscal tears, the location and tear pattern play a vital role in clinical management. Tears in the central white-white zone are less amenable to repair due to poor vascularity. Patients may be indicated for APM or non-surgical intervention depending on the tear pattern and symptoms. Non-surgical management for meniscal pathology includes non-steroidal anti-inflammatory drugs (NSAIDs), physical therapy (PT), and intraarticular injections to reduce inflammation and relieve symptoms. There have been several landmark multicenter randomized controlled trials (RCTs) studying the outcomes of APM compared to PT or sham surgery in symptomatic degenerative meniscal tears. These most notably include the 2013 Meniscal Tear in Osteoarthritis Research (MeTeOR) Trial, the 2018 ESCAPE trial, and the sham surgery-controlled Finnish Degenerative Meniscal Lesion Study (FIDELITY), which failed to identify substantial benefits of APM over nonoperative treatment or even placebo surgery. Despite an abundance of literature exploring outcomes of APM for degenerative meniscus tears, there is little consensus among surgeons about the drivers of good outcomes following APM. It is often difficult to determine if the presenting symptoms are secondary to the meniscus pathology or the degenerative disease in patients with concomitant OA. A central tenet of managing meniscal pathology is to preserve tissue whenever possible. Most RCTs show that exercise therapy may be non-inferior to APM in degenerative tears if repair is not possible. Given this evidence, patients who fail nonoperative treatment should be counseled regarding the risks of APM before proceeding to surgical management.
Keywords: Arthroscopic partial meniscectomy; Degenerative tear; Meniscal tear; Osteoarthritis; Physical therapy; Sham surgery; Traumatic tear.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Amanda Avila declares that she has no conflict of interest.
Kinjal Vasavada declares that she has no conflict of interest.
Dhruv Shankar declares that he has no conflict of interest.
Laith M. Jazrawi has received consulting fees from Flexion Therapeutics; research support from Arthrex, Mitek, and Smith & Nephew; and education support from Gotham Surgical and Arthrex.
Eric J Strauss has received consulting fees from Arthrex, Fidia, Flexion Therapeutics, the Joint Restoration Foundation, Organogenesis, Smith & Nephew, Subchondral Solutions, and Vericel; research support from Fidia, Organogenesis, and CartiHeal.
Figures
References
-
- Sihvonen R, Paavola M, Malmivaara A, Itälä A, Joukainen A, Kalske J, et al. Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial. Br J Sports Med. 2020;54(22):1332–1339. doi: 10.1136/bjsports-2020-102813. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
